A closer look at the technologies used by INOMAX hospitals
See more technologies
INOMAX hospitals
Manufacturing · New Jersey, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
6 State Route 173, Clinton, New Jersey, ...Phone Number
(908) 238-6600Website
www.inomax.comRevenue
$77 MillionIndustry
About INOMAX hospitals
Mallinckrodt Pharmaceuticals specializes in the production of INOmax, a nitric oxide gas for inhalation, primarily aimed at treating term and near-term neonates with hypoxic respiratory failure associated with pulmonary hypertension. Their offerings include innovative delivery systems that emphasize flexibility and automation, along with a comprehensive Total Care service that provides 24/7 support, device education, and technical assistance. The company is committed to improving patient outcomes in neonatal intensive care units (NICUs) through effective treatment solutions and ongoing support. With a legacy of service and reliability, Mallinckrodt continues to be a leader in the market for nitric oxide delivery systems.Explore more
SIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to INOMAX hospitals
Compare insights from companies similar to INOMAX hospitals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
INOMAX hospitals
$77M
201-500
Private
-
1998
N/A
$23M
51-200
Private
-
-
EA
Erin ArcarioDirector, US People Analytics and Human Resources Projects and Chief of Staff
INOMAX hospitals Tech Stack
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding INOMAX hospitals
Sign Up For FreeTo access detailed company insights
Mallinckrodt Pharmaceuticals specializes in the production of INOmax, a nitric oxide gas for inhalation, primarily aimed at treating term and near-term neonates with hypoxic respiratory failure associated with pulmonary hypertension. Their offerings include innovative delivery systems that emphasize flexibility and automation, along with a comprehe... Read More
